The Effect of High Dose Simvastatine on Multiple Myeloma

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

NCT00721734 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.

NCT01026701 ·Status: COMPLETED

A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma

NCT02230917 ·Status: WITHDRAWN ·Phase: PHASE2

Vinorelbine and Gemcitabine in Myeloma

NCT02791373 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

NCT00002556 ·Status: COMPLETED ·Phase: PHASE3

Protein Tyrosine Kinases (PTK) in Multiple Myeloma

NCT00165347 ·Status: COMPLETED ·Phase: PHASE2

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

NCT01220375 ·Status: COMPLETED ·Phase: PHASE2

Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid

NCT01772719 ·Status: TERMINATED ·Phase: NA

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

NCT04379817 ·Status: COMPLETED ·Phase: PHASE2

A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.

NCT06232096 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

NCT01087008 ·Status: COMPLETED ·Phase: PHASE4

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

NCT01508416 ·Status: COMPLETED

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

NCT03288480 ·Status: COMPLETED ·Phase: PHASE1

Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

NCT02474563 ·Status: COMPLETED

A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT05160584 ·Status: RECRUITING

Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.

NCT05163405 ·Status: COMPLETED

Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy

NCT00571168 ·Status: UNKNOWN ·Phase: PHASE3

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

NCT00006013 ·Status: COMPLETED ·Phase: PHASE2

Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib

NCT05184595 ·Status: UNKNOWN ·Phase: NA

Beta Alethine in Treating Patients With Myeloma

NCT00006466 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma

NCT03051841 ·Status: UNKNOWN ·Phase: PHASE1

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

NCT00547404 ·Status: WITHDRAWN ·Phase: PHASE1

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies

NCT02997813 ·Status: COMPLETED

Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma

NCT02302495 ·Status: COMPLETED ·Phase: PHASE2

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

NCT00205764 ·Status: COMPLETED ·Phase: PHASE3